NYSE - Nasdaq Real Time Price USD

Biohaven Ltd. (BHVN)

20.31
+0.06
+(0.27%)
As of 2:13:19 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
885,111
885,111
436,051
567,932
218,900
Operating Income
-885,111
-885,111
-436,051
-567,932
-218,900
Other Income Expense
39,424
39,424
26,500
-1,909
6,470
Pretax Income
-845,687
-845,687
-409,551
-569,841
-212,430
Tax Provision
735
735
-1,383
438
1,366
Net Income Common Stockholders
-846,422
-846,422
-408,168
-570,279
-213,796
Diluted NI Available to Com Stockholders
-846,422
-846,422
-408,168
-570,279
-213,796
Basic EPS
-9.37
-9.28
-5.73
-12.75
-5.97
Diluted EPS
-9.37
-9.28
-5.73
-12.75
-5.97
Basic Average Shares
85,959.15
91,234.34
71,200.53
44,741.32
35,822.51
Diluted Average Shares
85,959.15
91,234.34
71,200.53
44,741.32
35,822.51
Total Operating Income as Reported
-885,111
-885,111
-436,051
-567,932
-218,900
Total Expenses
885,111
885,111
436,051
567,932
218,900
Net Income from Continuing & Discontinued Operation
-846,422
-846,422
-408,168
-570,279
-213,796
Normalized Income
-846,422
-846,422
-408,168
-570,279
-213,796
EBIT
-885,111
-885,111
-436,051
-567,932
-218,900
EBITDA
-877,256
-877,256
-429,139
-566,546
-217,507
Reconciled Depreciation
7,855
7,855
6,912
1,386
1,393
Net Income from Continuing Operation Net Minority Interest
-846,422
-846,422
-408,168
-570,279
-213,796
Normalized EBITDA
-877,256
-877,256
-429,139
-566,546
-217,507
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/23/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IMVT Immunovant, Inc.
14.19
-0.77%
 
CYTK Cytokinetics, Incorporated
32.25
-0.71%
 
SRRK Scholar Rock Holding Corporation
30.73
-0.84%
 
PCVX Vaxcyte, Inc.
31.59
+0.43%
 
APLS Apellis Pharmaceuticals, Inc.
17.30
-2.86%
 
ARGX argenx SE
555.62
-2.37%
 
RARE Ultragenyx Pharmaceutical Inc.
35.59
-1.08%
 
BBIO BridgeBio Pharma, Inc.
34.55
-0.86%
 
PTCT PTC Therapeutics, Inc.
44.84
+5.48%
 
ARVN Arvinas, Inc.
6.70
-1.69%